Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SKLB-197 is able to act on ATR (IC50: 0.013 μM), but has little or no activity on the other 402 protein kinases. In vitro and in vivo, SKLB-197 has shown significant antitumour effects against ATM-deficient tumours.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 715.00 | |
50 mg | 6-8 weeks | $ 929.00 | |
100 mg | 6-8 weeks | $ 1,490.00 |
Description | SKLB-197 is able to act on ATR (IC50: 0.013 μM), but has little or no activity on the other 402 protein kinases. In vitro and in vivo, SKLB-197 has shown significant antitumour effects against ATM-deficient tumours. |
Molecular Weight | 424.5 |
Formula | C25H24N6O |
CAS No. | 2713577-16-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SKLB-197 2713577-16-1 inhibitor inhibit